Abstract
Objective
To investigate the protective effects and mechanism of Chinese herbal compound Tongxinluo Capsule (通心络胶囊, TXL) on the Parkin-mediated mitophagy and the ubiquitin-proteasome system in a rat model of myocardial ischemia-reperfusion injury (MIRI).
Methods
Seventy adult male Sprague-Dawley rats were randomly divided into 7 groups: sham group, MIRI group, low- and high-dose TXL (0.5 and 1 g·kg-1·d-1, respectively) groups, atorvastatin (ATV) group (7.2 g·kg-1·d-1), chloroquine (CQ) group (10 g·kg-1·d-1), and highdose TXL + CQ group. After pharmacological administration for 7 days, rats underwent left anterior descending artery ligation surgery to establish the MIRI models with 50 min ischemia followed by 4 h reperfusion. Blood was taken for cardiac troponin I (cTnI) detection and hearts were harvested for infarct staining and apoptosis detection. The autophagy or mitophagy proteins and ubiquitinated proteins were detected by Western blotting.
Results
Compared with the sham group, the MIRI group exhibited a larger infarcted area (27.13%±0.01%, P<0.01), a higher apoptotic index (34.33%±2.03% vs.1.81%±0.03%, P<0.01), and higher cTnI expression (14.18±1.01 vs. 7.96±0.32, P<0.01). The mitochondrial integrity was damaged in the MIRI group, while TXL and ATV alleviated the damage of MIRI. More autophagosomes were observed in the high-dose TXL group than in the MIRI group (7.00±0.58 vs. 4.33±1.15, P<0.05). More amounts of PTEN-induced putative kinase protein 1 (PINK1) and Parkin translocated onto the mitochondria were detected in the high-dose TXL group than in the MIRI group (P<0.05). The ubiquitin response was signifificantly downregulated in the high-dose TXL group relative to the MIRI group (P<0.05). CQ administration abolished the activation of autophagy flux and the PINK1/ Parkin pathway induced by high-dose of TXL.
Conclusions
TXL ameliorates MIRI via activating Parkin-mediated mitophagy in rats. The downregulation of the ubiquitin-proteasome system is also involved.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics—2017 update. A report from the American Heart Association}. Circulation 2017;135:E146–E603.
Li F, Fan X, Zhang Y, Pang L, Ma X, Song M, et al. Cardioprotection by combination of three compounds from Shengmai preparations in mice with myocardial ischemia/reperfusion injury through AMPK activation-mediated mitochondrial fission. Sci Rep 2016;6:37114.
Hao M, Zhu S, Hu L, Zhu H, Wu X, Li Q. Myocardial ischemic postconditioning promotes autophagy against ischemia reperfusion injury via the activation of the nNOS/AMPK/mTOR pathway. Int J Molecul Sci 2017;18:614.
Thind GS, Agrawal PR, Hirsh B, Saravolatz L, Chen-Scarabelli C, Narula J, et al. Mechanisms of myocardial ischemiareperfusion injury and the cytoprotective role of minocycline: scope and limitations. Future Cardiol 2015;11:61–76.
Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations. Nat Cell Biol 2007;9:1102–1109.
Jin M, Liu X, Klionsky DJ. SnapShot: selective autophagy. Cell 2013;152:368–368.e2.
Matsui Y, Kyoi S, Takagi H, Hsu CP, Hariharan N, Ago T, et al. Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion. Autophagy 2008;4:409–415.
Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and beclin 1 in mediating autophagy. Circul Res 2007;100:914–922.
Anzell AR, Maizy R, Przyklenk K, Sanderson TH. Mitochondrial quality control and disease: insights into ischemia-reperfusion injury. Molecul Neurobiol 2018;55:2547–2564.
Jin Q, Li R, Hu N, Xin T, Zhu P, Hu S, et al. DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the Mffrequired mitochondrial fission and BNIP3-related mitophagy via the JNK pathways. Redox Biol 2018;14:576–587.
Majetschak M, Patel MB, Sorell LT, Liotta C, Li S, Pham SM. Cardiac proteasome dysfunction during cold ischemic storage and reperfusion in a murine heart transplantation model. Biochem Biophysic Res Commun 2008;365:882–888.
Li J, Horak KM, Su H, Sanbe A, Robbins J, Wang X. Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. J Clin Invest 2011;121:3689–3700.
Fan T, Huang Z, Chen L, Wang W, Zhang B, Xu Y, et al. Associations between autophagy, the ubiquitin-proteasome system and endoplasmic reticulum stress in hypoxia-deoxygenation or ischemia-reperfusion. Eur J Pharmacol 2016;791:157–167.
Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Human Molecul Genetics 2011;20:1726–1737.
Wang HJ, Huang YW, Sun J. Effect of Tongxinluo Capsule on function of vascular endothelium in patients with unstable angina pectoris. Chin J Integr Tradit West Med (Chin) 2003;23:587–589.
You SJ, Yang YJ, Chen KJ, Gao RL, Wu YJ, Zhang J, et al. The protective effects of Tong-xin-luo on myocardium and microvasculature after reperfusion in acute myocardial infarction. Chin J Cardiol (Chin) 2005;33:433–437.
You SJ, Yang YJ, Chen KJ, Gao RL, Wu YJ, Zhang J, et al. The protective effects of Tong-xin-luo on myocardium and microvasculature after reperfusion in acute myocardial infarction. Chin J Cardiol (Chin) 2005;33:433–437.
Zhang L, Li Y, Yang BS, Li L, Wang XZ, Ge ML, et al. A multicenter, randomized, double-blind, and placebo-controlled study of the effects of Tongxinluo Capsules in acute coronary syndrome patients with high on-treatment platelet reactivity. Chine Med J 2018;131:508–515.
Li M, Li C, Chen S, Sun Y, Hu J, Zhao C, et al. Potential effectiveness of Chinese patent medicine Tongxinluo Capsule for secondary prevention after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol 2018;9:830.
Huang X, Wang Y, Wang Y, Yang L, Wang J, Gao Y. Ophiopogonin D reduces myocardial ischemia-reperfusion injury via upregulating CYP2J3/EETs in rats. Cell Physiol Biochem 2018;49:1646–1658.
Peng S, Xu LW, Che XY, Xiao QQ, Pu J, Shao Q, et al. Atorvastatin inhibits inflammatory response, attenuates lipid deposition, and improves the stability of vulnerable atherosclerotic plaques by modulating autophagy. Front Pharmacol 2018;9:438.
Lippai M, Lőw P. The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy. BioMed Res Int 2014;2014:1–11.
Shin B, Cowan DB, Emani SM, Del Nido PJ, McCully JD. Mitochondrial transplantation in myocardial ischemia and reperfusion injury. Adv Exp Med Biol 2017;982:595–619.
Hall AR, Burke N, Dongworth RK, Hausenloy DJ. Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease. Br J Pharmacol 2014;171:1890–1906.
Huang C, Andres AM, Ratliff EP, Hernandez G, Lee P, Gottlieb RA. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One 2011;6:e20975.
Kubli DA, Cortez MQ, Moyzis AG, Najor RH, Lee Y, Gustafsson ÅB. PINK1 is dispensable for mitochondrial recruitment of parkin and activation of mitophagy in cardiac myocytes. PLoS One 2015;10:e0130707.
Kubli DA, Zhang X, Lee Y, Hanna RA, Quinsay MN, Nguyen CK, et al. Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction. J Biol Chem 2013;288:915–926.
Wu T, Harrison RA, Chen X, Ni J, Zhou L, Qiao J, et al. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris. Cochrane Database Syst Rev 200618:CD004474.
Cui H, Li N, Li X, Qi K, Li Q, Jin C, et al. Tongxinluo modulates cytokine secretion by cardiac microvascular endothelial cells in ischemia/reperfusion injury. Am J Transl Res 2016;8:4370–4381.
Li Q, Cui HH, Yang YJ, Li XD, Chen GH, Tian XQ, et al. Quantitative proteomics analysis of ischemia/reperfusion injury-modulated proteins in cardiac microvascular endothelial cells and the protective role of Tongxinluo. Cell Physiol Biochem 2017;41:1503–1518.
Chen ZQ, Hong L, Wang H, Yin QL. Effects of Tongxinluo Capsule on platelet activating factor, vascular endothelial function, blood flow of thrombolysis in myocardial infarction in acute myocardial infarction patients after delayed percutaneous coronary intervention. Chin J Integr Tradit West Med (Chin) 2016;36:415–420.
Chen ZQ, Hong L, Wang H. Effect of Tongxinluo Capsule on platelet activities and vascular endothelial functions as well as prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Chin J Integr Tradit West Med (Chin) 2011;31:487–491.
Wang B, Yang Q, Bai WW, Xing YF, Lu XT, Sun YY, et al. Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation. PLoS One 2014;9:e98047.
Li Q, Li N, Cui HH, Tian XQ, Jin C, Chen GH, et al. Tongxinluo exerts protective effects via anti-apoptotic and pro-autophagic mechanisms by activating AMPK pathway in infarcted rat hearts. Exp Physiol 2017;102:422–435.
Scarlatti F, Maffei R, Beau I, Codogno P, Ghidoni R. Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ 2008;15:1318–1329.
Zhu JH, Horbinski C, Guo F, Watkins S, Uchiyama Y, Chu CT. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am J Pathol 2007;170:75–86.
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 2016;12:1–222.
Su, H, X. Wang. p62 stages an interplay between the ubiquitin-proteasome system and autophagy in the heart of defense against proteotoxic stress. Trends Cardiovascul Med 2011;21:224–228.
Rothermel BA, Hill JA. The heart of autophagy-deconstructing cardiac proteotoxicity. Autophagy 2008;4:932–935.
Zheng Q, Su H, Ranek MJ, Wang X. Autophagy and p62 in cardiac proteinopathy. Circul Res 2011;109:296–U164.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Basic Research Program (973 Program) of China (No. 2012CB518601)
Rights and permissions
About this article
Cite this article
Yang, Hx., Wang, P., Wang, Nn. et al. Tongxinluo Ameliorates Myocardial Ischemia-Reperfusion Injury Mainly via Activating Parkin-Mediated Mitophagy and Downregulating Ubiquitin-Proteasome System. Chin. J. Integr. Med. 27, 542–550 (2021). https://doi.org/10.1007/s11655-019-3166-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-019-3166-8